id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-N-0063-0004,FDA,FDA-1995-N-0063,"Current Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Extension of Reopening of the Comment Period",Proposed Rule,Extension of Comment Period,2003-07-02T04:00:00Z,2003,7,2003-06-27T04:00:00Z,2003-08-27T03:59:59Z,2014-05-03T01:05:13Z,68 FR 38247,0,0,090000648056cb33
FDA-1995-N-0063-0001,FDA,FDA-1995-N-0063,"Current Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports for the Production of Infant Formula; Reopening of the Comment Period",Proposed Rule,Reopening of Comment Period,2003-05-01T04:00:00Z,2003,5,2003-05-01T04:00:00Z,2003-06-28T03:59:59Z,2014-07-17T01:03:16Z,,0,0,090000648056caaf